Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christopher C LaGanke, MD
North Central Neurology Associates, PC
Principal Investigator - David H Mattson, MD
Indiana University Health Neuroscience Center
Principal Investigator - Keith R Edwards, MD, FAAD
MS Center of Northeastern NY/Empire Neurology
Principal Investigator - Lael A Stone, MD
The Cleveland Clinic
Principal Investigator - Lawrence M Samkoff, MD
University of Rochester
Principal Investigator - Omar Khan, MD
Wayne State University - University Health Center
Principal Investigator - Pavle Repovic, MD
Swedish Medical Center
Principal Investigator - Sharon Lynch, MD
University of Kansas Medical Center
Principal Investigator - T H Rao, MD
The Neurological Institute, PA
Principal Investigator - Timothy Vollmer, MD
University of Colorado Hospital, Anschutz Inpatient Pavilion
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- North Central Neurology Associates, Pc
Cullman, Alabama, United States
- University of Colorado Hospital, Aschutz Inpatient Pavilion
Aurora, Colorado, United States
- Indiana University Health Neuroscience Center
Indianapolis, Indiana, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Wayne State University - University Health Center
Detroit, Michigan, United States
- Ms Center of Northeastern Ny/empire Neurology
Latham, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- the Neurological Institute, Pa
Charlotte, North Carolina, United States
- the Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Swedish Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2012
- Primary completion
- 30 Nov 2014
- Completion
- 30 Nov 2014
- Last update posted
- 6 Feb 2015
- Registered enrollment
- 50
- Registry id
- NCT01764737
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.